Refusal of postoperative radiotherapy and its association with survival in head and neck cancer

被引:17
作者
Schwam, Zachary G. [1 ]
Husain, Zain [2 ]
Judson, Benjamin L. [3 ]
机构
[1] Yale Univ, Sch Med, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA
[3] Yale Univ, Sch Med, Dept Surg, Otolaryngol Sect, 333 Cedar St,POB 208041, New Haven, CT 06520 USA
关键词
Head and neck cancer; Treatment refusal; Patient outcome assessment; Adjuvant radiotherapy; SQUAMOUS-CELL CARCINOMA; LOCALLY ADVANCED HEAD; RADIATION-THERAPY; HUMAN-PAPILLOMAVIRUS; POSITIVE HEAD; RISK; CHEMOTHERAPY; SURGERY; DEINTENSIFICATION; INTENSIFICATION;
D O I
10.1016/j.radonc.2015.10.013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purpose: Administering postoperative radiotherapy (PORT) is associated with improved survival and slower disease progression in select head and neck cancer patients. Predictive factors for PORT refusal have not been described in this population. Materials and methods: Retrospective analysis of 6127 head and neck cancer patients who received or refused PORT in the National Cancer Database (2003-2006) was performed. Statistical analysis included Chi-square, multivariable logistic regression, Kaplan-Meier, and Cox proportional hazards analysis. Results: In total, 247 patients (4.0%) refused PORT. Three-year overall survival was 62.8% versus 53.4% for those who received and refused PORT, respectively. PORT refusers were more likely to have negative nodes than those who underwent PORT (37.4% versus 20.1%, p <.001). In multivariate analysis, predictive factors for refusing PORT included living far from the treatment facility (OR 1.92), having negative nodes (OR 2.14), and Charlson score of >= 2 (OR 2.14) (all p <= .001). PORT refusal was associated with increased mortality (hazard ratio 1.20, p =.044). Conclusions: A significant proportion of head and neck cancer patients refused PORT; this was associated with compromised overall survival. Predictive factors for PORT refusal included socioeconomic, demographic, and pathologic variables. Elucidating root causes of refusal may lead to interventions that improve long-term outcomes. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:343 / 350
页数:8
相关论文
共 47 条
[1]   Refusal of Curative Radiation Therapy and Surgery Among Patients With Cancer [J].
Aizer, Ayal A. ;
Chen, Ming-Hui ;
Parekh, Arti ;
Choueiri, Toni K. ;
Hoffman, Karen E. ;
Kim, Simon P. ;
Martin, Neil E. ;
Hu, Jim C. ;
Quoc-Dien Trinh ;
Nguyen, Paul L. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 89 (04) :756-764
[2]  
American College of Surgeons, NAT CANC DAT
[3]   Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer [J].
Ang, K. Kian ;
Harris, Jonathan ;
Wheeler, Richard ;
Weber, Randal ;
Rosenthal, David I. ;
Nguyen-Tan, Phuc Felix ;
Westra, William H. ;
Chung, Christine H. ;
Jordan, Richard C. ;
Lu, Charles ;
Kim, Harold ;
Axelrod, Rita ;
Silverman, C. Craig ;
Redmond, Kevin P. ;
Gillison, Maura L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (01) :24-35
[4]   Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer [J].
Ang, KK ;
Trotti, A ;
Brown, BW ;
Garden, AS ;
Foote, RL ;
Morrison, WH ;
Geara, FB ;
Klotch, DW ;
Goepfert, H ;
Peters, LJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 51 (03) :571-578
[5]  
[Anonymous], FAC ONC REG DAT STAN
[6]  
[Anonymous], NAT CANC DAT BAS DAT
[7]  
[Anonymous], 2013, International Classification of disease for Oncology
[8]  
[Anonymous], 2002, AJCC CANC STAGING HD
[9]   Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: Final report of a randomized trial [J].
Bachaud, JM ;
CohenJonathan, E ;
Alzieu, C ;
David, JM ;
Serrano, E ;
DalySchveitzer, N .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 36 (05) :999-1004
[10]  
Balermpas P, 2015, INT J CANC IN PRESS